MET ALTERATION

Clinical trials for MET ALTERATION explained in plain language.

Never miss a new study

Get alerted when new MET ALTERATION trials appear

Sign up with your email to follow new studies for MET ALTERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug duo aims to outsmart resistant lung cancer

Disease control Not yet recruiting

This study is testing a new two-drug combination for people with a specific type of advanced lung cancer that has spread. The goal is to find a safe dose and see if the combination can help shrink tumors or stop them from growing. The trial is for adults whose cancer has a geneti…

Matched conditions: MET ALTERATION

Phase: PHASE1, PHASE2 • Sponsor: Beijing Pearl Biotechnology Limited Liability Company • Aim: Disease control

Last updated Mar 20, 2026 14:48 UTC

MET ALTERATION

Get alerted when new MET ALTERATION trials appear

New drug duo aims to outsmart resistant lung cancer